Psychopharmacology

, Volume 84, Issue 1, pp 12–15 | Cite as

The opiate quasiwithdrawal syndrome in rhesus monkeys: Comparison of naloxone-precipitated withdrawal to effects of cholinergic agents

  • Jonathan L. Katz
  • Rita J. Valentino
Original Investigations

Abstract

The effects of the cholinergic agents UM-1046 (3-cyclopropyl-methyl-1,2,3,4,5,6-hexahydro-8-hydroxy-6-methyl-3-benzazocine hydrochloride) and physostigmine in normal rhesus monkeys were compared to naloxone-precipitated withdrawal in morphine-dependent subjects. The two cholinergic drugs produced effects that resembled one another, as well as some of the effects of naloxone in morphine-dependent subjects. The constellation of signs produced by the cholinergic drugs, while overlapping, was not identical to that produced by naloxone in opiate-dependent subjects. Although cholinergic agents produce many of the signs of opiate withdrawal, the withdrawal syndrome in its complete manifestation involves many different neurotransmitter systems.

Key words

Opiate dependence Opiate withdrawal Quasiwithdrawal syndrome Precipitated withdrawal Opiate antagonists UM-1046 Physostigmine Naloxone Acetylcholine release Rhesus monkeys 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aceto MD, Carchman RA, Harris LS, Flora RE (1978) Caffeine elicited withdrawal signs in morphine-dependent rhesus monkeys. Eur J Pharmacol 50:203–207Google Scholar
  2. Aceto MD, Flora RE, Harris LS (1977) The effects of naloxone and nalorphine during the development of mophrine dependence in rhesus monkeys. Pharmacology 15:1–9Google Scholar
  3. Aceto MD, Harris LS (1978) 3-Isobutyl-1-methylxanthine (IBMX) elicited withdrawal signs in morphine-dependent rhesus monkeys. Fed Proc 37:764Google Scholar
  4. Aghajanian GK (1978) Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature 276:186–188Google Scholar
  5. Collier HOJ (1974) The concept of the quasi-abstinence effect and its use in the investigation of dependence mechanisms. Pharmacology 11:58–61Google Scholar
  6. Collier HOJ, Cuthbert NJ, Francis DL (1981) Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines. Fed Proc 40:1513–1518Google Scholar
  7. Cowan A (1981) Quasi-morphine withdrawal syndrome: recent developments. Fed Proc 40:1489–1490Google Scholar
  8. Deneau GA, Seevers MH (1963) Evaluation of new compounds for morphine-like physical dependence capacity. In: Proceedings of the 25th Annual Meeting, Committee on Problems of Drug Dependence, NAS, Washington, DC, Addendum 25Google Scholar
  9. Enberg G, Svensson TH (1980) Pharmacologic analysis of a cholinergic receptor-mediated regulation of brain norepinephrine neurons. J Neural Transm 49:137–150Google Scholar
  10. Gold MS, Redmond DE, Keber HD (1978) Clonidine in opiate withdrawal. Lancet I:929–930Google Scholar
  11. Guyenet PG, Aghajanian GK (1979) Ach, substance P and met-enkephalin in the locus coeruleus: Pharmacological evidence for independent sites of action. Eur J Pharmacol 53:319–328Google Scholar
  12. Redmond Jr DE (1981) Clonidine and the primate locus coeruleus: Evidence suggesting anxiolytic and antiwithdrawal effects. In: Lal H, Fielding S (eds) Psychopharmacology of clonidine. Liss, New York, pp 147–163Google Scholar
  13. Redmond Jr DE, Huang YH (1982) The primate locus coeruleus and effects of clonidine on opiate withdrawal. J Clin Psychiatry 43:25–29Google Scholar
  14. Redmond Jr DE, Huang YH, Snyder DR, Maas JW (1976) Behavioral effects of stimulation of the locus coeruleus in the stumptail monkey (Macaca arctoides). Brain Res 116:502–510Google Scholar
  15. Swain HH, Seevers MH (1975) Evaluation of new compounds for morphine-like physical dependence in the rhesus monkey. In: Proceedings of the 37th Annual Meeting, Committee on Problems of Drug Dependence. Washington DC, pp 773–795Google Scholar
  16. Valentino RJ, Aston-Jones G (1982) Activation of locus coreuleus neurons in the rat by UM-1046, a drug that mimics opiate withdrawal in normal animals. Soc Neurosci Abstr 8:228Google Scholar
  17. Valentino RJ, Herling S, Woods JH (1983) Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons. J Pharmacol Exp Ther 224:307–313Google Scholar
  18. Valentino RJ, Smith, CB, Woods JH (1978) Release of acetylcholine in the guinea-pig ileum by a benzazocine which produces effects similar to the narcotic abstinence syndrome. In: Proceedings of the 40th Annual Meeting, Committee on Problems of Drug Dependence. NAS-NRC, Washington DC, pp 753–767Google Scholar
  19. Valentino RJ, Smith CB, Woods JH (1979) An unusual benzazocine elicits acetylcholine release in the isolated guinea pig ileum. Nature 281:370–372Google Scholar
  20. Valentino RJ, Smith CB, Woods JH (1981) Physiological and behavioral approaches to the study of the quasi-morphine withdrawal syndrome. Fed Proc 40:1502–1507Google Scholar
  21. Villarreal JE (1973) The effects of morphine agonists and antagonists in morphine-dependent rhesus monkeys. In: Kosterlitz H, Collier HOJ, Villarreal JE (eds) Agonist and antagonist actions of narcotic drugs. University Park Press, Baltimore, pp 73–93Google Scholar
  22. Villarreal JE, Karbowski MG (1974) The actions of narcotic antagonists in morphine-dependent rhesus monkeys. Adv Biochem Psychopharmacol 8:273–289Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • Jonathan L. Katz
    • 1
  • Rita J. Valentino
    • 2
  1. 1.NIDA Addition Research CenterBaltimoreUSA
  2. 2.Department of PharmacologyGeorge Washington University Medical CenterWashington, DCUSA

Personalised recommendations